Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cabot (CBT) Cash & Equivalents (2016 - 2025)

Cabot (CBT) has disclosed Cash & Equivalents for 17 consecutive years, with $230.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 25.68% to $230.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $230.0 million, a 25.68% increase, with the full-year FY2025 number at $258.0 million, up 15.7% from a year prior.
  • Cash & Equivalents was $230.0 million for Q4 2025 at Cabot, down from $258.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $258.0 million in Q3 2025 to a low of $146.0 million in Q1 2021.
  • A 5-year average of $207.0 million and a median of $207.0 million in 2022 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 47.26% in 2022, then fell 25.0% in 2024.
  • Cabot's Cash & Equivalents stood at $179.0 million in 2021, then increased by 6.15% to $190.0 million in 2022, then grew by 28.42% to $244.0 million in 2023, then dropped by 25.0% to $183.0 million in 2024, then rose by 25.68% to $230.0 million in 2025.
  • Per Business Quant, the three most recent readings for CBT's Cash & Equivalents are $230.0 million (Q4 2025), $258.0 million (Q3 2025), and $239.0 million (Q2 2025).